SCHEMBL38663361

SCHEMBL38663361

CC(C)(C)OC(=O)N1CCN(c2cc(Cl)cnn2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 2/20 0.49
▸ SKP1 P63208 2/20 0.49
▸ SKP2 Q13309 2/20 0.49
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ SUV39H2 Q9H5I1 1/20 0.46
▸ GPR119 Q8TDV5 2/20 0.46
▸ MAP4K4 O95819 1/20 0.45
▸ CNR1 P21554 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ RET P07949 1/20 0.44
▸ ADK P55263 1/20 0.44
▸ SMARCA2 P51531 1/20 0.44
▸ SMARCA4 P51532 1/20 0.44
▸ PBRM1 Q86U86 1/20 0.44
▸ STS P08842 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18790713 1.00 CKS1B (0.49) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL15114941 0.84 CKS1B (0.48) CKS1BSKP1SKP2SUV39H2GPR119
SCHEMBL4425180 0.82 TRPV1 (0.51) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL4309116 0.82 CKS1B (0.55) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL38664512 0.81 SMARCA2 (0.48) MEN1KMT2AGPR119CNR1SMARCA2
SCHEMBL3164551 0.80 GPR119 (0.54) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL30962028 0.80 MAPT (0.49) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL27717174 0.79 GPR119 (0.53) CKS1BSKP1SKP2GPR119MAP4K4
SCHEMBL1686074 0.79 GPR119 (0.52) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL32129014 0.79 GPR119 (0.52) CKS1BSKP1SKP2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106389-A1 NMT INHIBITOR AND USE THEREOF 주식회사 이노보테라퓨틱스 2026-05-21 — — WO disclosed
Send feedback